Pharmaceuticals

Artificial Tears Market to Reach $4.76 Billion by 2029, Growing at a CAGR of 6.2%

November 10, 2025 by Marketing Posting

Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20

What Is The Global Market Value Of The Artificial Tears Industry In 2025?

The artificial tears market has experienced significant growth in recent years. This market is set to increase from $3.55 billion in 2024 to $3.74 billion in 2025, achieving a compound annual growth rate (CAGR) of 5.5%. Historically, this expansion has been driven by factors such as an aging population, increased prolonged screen time, growing healthcare expenditure, a transition from prescription to over-the-counter products, and shifts in regulatory frameworks.

The artificial tears market is projected to experience substantial expansion over the upcoming years. This market is anticipated to reach a valuation of $4.76 billion by 2029, exhibiting a compound annual growth rate (CAGR) of 6.2%. This anticipated growth throughout the forecast period stems from factors such as the rising incidence of dry eye syndrome, greater use of contact lenses, worldwide urbanization, escalating pollution levels, and the expansion of e-commerce. Key trends influencing the market during this period encompass technological innovations, the incorporation of AI and other technologies, collaborations with healthcare professionals, the inclusion of natural components, progress in product development, sophisticated drug delivery mechanisms, and the introduction of sustainable and environmentally friendly offerings.

Unlock Your Free Sample Report for Exclusive Market Data:

https://www.thebusinessresearchcompany.com/sample.aspx?id=13799&type=smp

What Are The Emerging Market Drivers Creating New Opportunities In The Artificial Tears Industry?

The growing incidence of dry eye disease is projected to drive expansion within the artificial tear market. This condition, characterized by insufficient or poor-quality tear production, leads to irritation and discomfort, which artificial tears address by supplementing natural tear production to provide lubrication and relief. For instance, a March 2022 survey of 5,000 individuals by Macquarie University, an Australia-based public research university, revealed that among respondents aged 50 and above, 13% (15 out of 120) exhibited clinical indicators of dry eye disease (DED), broken down into 8.2% mild, 2.5% moderate, and 1.6% severe cases. Furthermore, in March 2022, Eyes On Eyecare, a US-based digital ophthalmology news provider, noted an increase in the utilization of prescription and in-office treatments for dry eye disease, from 5.8% in 2021 to 7.56% in 2022, with specific prescription treatments like topical steroids seeing a substantial rise from 0.9% to 9.1% during the identical timeframe. Consequently, the increasing prevalence of dry eye disease is acting as a key driver for the growth of the artificial tear market.

How Is The Artificial Tears Market Classified Into Different Segments?

The artificial tears market covered in this report is segmented –

1) By Type: Glycerin Tears, Cellulose Tears, Oil-Based Emulsion Tears, Polyethylene Glycol-based Tears, Sodium Hyaluronate Based Artificial Tears, Propylene Glycol-based Tears

2) By Dosage: Suspensions, Solution, Ointment, Emulsion, Gel, Spray

3) By Indication: Dry Eye Syndrome, Allergies, Infections, UV And Blue Light Protection, Contact Lens Moisture Retention, Other Indications

4) By Distribution: Retail Pharmacies, Hospital Pharmacies, Online Pharmacies, Ophthalmic Stores

Subsegments:

1) By Glycerin Tears: Preserved Glycerin Tears, Preservative-Free Glycerin Tears

2) By Cellulose Tears: Hydroxypropyl Methylcellulose (HPMC) Tears, Carboxymethylcellulose (CMC) Tears

3) By Oil-Based Emulsion Tears: Mineral Oil-based Tears, Castor Oil-based Tears

4) By Polyethylene Glycol-based Tears: PEG 400 Tears, PEG 3350 Tears

5) By Sodium Hyaluronate Based Artificial Tears: Low Molecular Weight Sodium Hyaluronate Tears, High Molecular Weight Sodium Hyaluronate Tears

6) By Propylene Glycol-based Tears: Preserved Propylene Glycol Tears, Preservative-Free Propylene Glycol Tears

Which Competitive Trends Are Defining The Artificial Tears Market Structure?

Leading companies in the artificial tears market are developing products that incorporate advanced technologies, such as patented PureFlow technology, to enhance both product safety and usability. This patented PureFlow technology refers to a specialized delivery system utilizing a one-way valve to ensure the sterile dispensing of preservative-free eye drops, thereby preventing contamination and maintaining product integrity. For instance, in January 2022, Alcon Inc., a Switzerland-based medical device and pharmaceutical company, launched Systane Complete Preservative-Free Lubricant Eye Drops. These sophisticated artificial tears are specifically formulated to alleviate symptoms associated with all major types of dry eye, including evaporative dry eye and aqueous tear deficiency. As a preservative-free solution, they deliver up to eight hours of sustained relief by hydrating and protecting every layer of the tear film. Leveraging nano-droplet technology, the drops provide rapid hydration to the eye surface, which helps prevent tear evaporation and offers quick, effective comfort. Packaged in a convenient multi-dose bottle featuring PureFlow technology, its design ensures safety by preventing contamination, making it an excellent choice for regular users and individuals with sensitive eyes.

Who Are The Prominent Global Companies Shaping The Artificial Tears Market?

Major companies operating in the artificial tears market report are Pfizer Inc., Johnson & Johnson, AbbVie Inc., Novartis AG, Abbott Laboratories, Otsuka Pharmaceutical Co. Ltd., Alcon, Bausch Health Companies Inc., Sun Pharmaceutical Industries Ltd., Dr Reddy’s Laboratories, Santen Pharmaceutical Co. Ltd., Lupin Limited, Rohto Pharmaceutical Co. Ltd., Prestige Consumer Healthcare Inc., Thea Pharma Inc., OPTIMA pharma GmbH, Sentiss Pharma Pvt. Ltd., VISUfarma B.V., OASIS Medical Inc., Hilco Vision, Similasan Corporation, Eyevance Pharmaceuticals LLC, Nicox S.A., I-MED Pharma Inc., Velocity Pharma LLC

Download The Full Report For Exclusive Market Findings:

https://www.thebusinessresearchcompany.com/report/artificial-tears-global-market-report

How Do Regional Market Performances Compare Within The Artificial Tears Industry?

North America was the largest region in the artificial tears market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the artificial tears market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Version Of The Artificial Tears Market Report:

https://www.thebusinessresearchcompany.com/customise?id=13799&type=smp

Browse Through More Reports Similar to the Global Artificial Tears Market 2025, By The Business Research Company

Artificial Intelligence Chipsets Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/artificial-intelligence-chipsets-global-market-report

Artificial Intelligence Software As A Service Saas Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/artificial-intelligence-software-as-a-service-saas-global-market-report

Artificial Intelligence In Healthcare Diagnosis Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/artificial-intelligence-in-healthcare-diagnosis-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795